Creative Medical Technology Holdings, Inc.: stockholders equity

What this measure means

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Creative Medical Technology Holdings, Inc.: total assets
• Creative Medical Technology Holdings, Inc.: total liabilities
• Creative Medical Technology Holdings, Inc.: cash and cash equivalents
• Creative Medical Technology Holdings, Inc.: net income or loss
• Creative Medical Technology Holdings, Inc.: operating cash flow
• Creative Medical Technology Holdings, Inc.: revenue
• Creative Medical Technology Holdings, Inc.: financing cash flow
• Creative Medical Technology Holdings, Inc.: investing cash flow
• Creative Medical Technology Holdings, Inc.: retained earnings or deficit
• Creative Medical Technology Holdings, Inc.: basic weighted-average shares
• Creative Medical Technology Holdings, Inc.: diluted weighted-average shares
• Creative Medical Technology Holdings, Inc.: basic earnings per share
• Creative Medical Technology Holdings, Inc.: diluted earnings per share
• Creative Medical Technology Holdings, Inc.: share-based compensation expense
• Creative Medical Technology Holdings, Inc.: operating income or loss
• Creative Medical Technology Holdings, Inc.: current assets
• Creative Medical Technology Holdings, Inc.: interest expense
• Creative Medical Technology Holdings, Inc.: current liabilities
• Creative Medical Technology Holdings, Inc.: current accounts payable
• Creative Medical Technology Holdings, Inc.: net finite-lived intangible assets
• Creative Medical Technology Holdings, Inc.: net current accounts receivable
• Creative Medical Technology Holdings, Inc.: common-stock repurchase payments
• Creative Medical Technology Holdings, Inc.: operating expenses
• Creative Medical Technology Holdings, Inc.: net inventory
• Creative Medical Technology Holdings, Inc.: gross profit
• Creative Medical Technology Holdings, Inc.: cost of revenue
• Creative Medical Technology Holdings, Inc.: selling, general and administrative expense
• Creative Medical Technology Holdings, Inc.: research and development expense

Inspect the source

Entity

Creative Medical Technology Holdings, Inc. / CIK 0001187953

Captured

2026-09-20T07:45:17.099Z

SEC response SHA-256

89e881c0f2d97477b4adfc3e19e7ae581dc54b90e3254331c852038e8d4c6961

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001187953.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))